Cargando…

Arsenic trioxyde in the treatment of HTLV1 associated ATLL

Detalles Bibliográficos
Autores principales:	Suarez, Felipe, Marcais, Ambroise, Ghez, David, Delarue, Richard, Deau-Fischer, Benedicte, Aoun, Charbel, Sicre de Fontbrune, Flore, Ysebaert, Laurent, Asnafi, Vahid, Canioni, Daniele, deThe, Hugue, Bazarbachi, Ali, Hermine, Olivier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112773/ http://dx.doi.org/10.1186/1742-4690-8-S1-A59

Ejemplares similares

ATLL introduction: is there a standard of care for treatment of adult T cell Leukemia Lymphoma?
por: Bazarbachi, Ali, et al.
Publicado: (2014)

Arsenic trioxide (As(2)O(3)) as a maintenance therapy for adult T cell leukemia/lymphoma
por: Marçais, Ambroise, et al.
Publicado: (2020)

The Emerging Role of miRNAs in HTLV-1 Infection and ATLL Pathogenesis
por: Moles, Ramona, et al.
Publicado: (2015)

HTLV-1, ATLL, refractory hypercalcaemia and HIV-1 co-infection
por: Laher, Abdullah E, et al.
Publicado: (2018)

HTLV-1, ATLL, severe hypercalcaemia and HIV-1 co-infection: an overview
por: Laher, Abdullah Ebrahim, et al.
Publicado: (2018)

High HTLV-I proviral load in patients with HAM/TSP and ATLL but not with other disorders
por: Altamirano, Natalia, et al.
Publicado: (2011)

Targeting HTLV-1 Activation of NFκB in Mouse Models and ATLL Patients
por: Rauch, Daniel A., et al.
Publicado: (2011)

Evaluation of the role of TAX, HBZ, and HTLV-1 proviral load on the survival of ATLL patients
por: Akbarin, Mohammad Mehdi, et al.
Publicado: (2017)

Clinical Trials of Adult T-Cell Leukaemia/Lymphoma Treatment
por: Marçais, Ambroise, et al.
Publicado: (2012)

HTLV-1 infection of Humanized SCID mice recapitulates Adult T-cell Leukemia/Lymphoma (ATLL) development
por: Banerjee, Prabal, et al.
Publicado: (2009)

A Preclinical Model for the ATLL Lymphoma Subtype With Insights Into the Role of Microenvironment in HTLV-1-Mediated Lymphomagenesis
por: Vicario, Mattia, et al.
Publicado: (2018)

Dual cytoplasmic and nuclear localization of HTLV-1-encoded HBZ protein is a unique feature of adult T-cell leukemia
por: Forlani, Greta, et al.
Publicado: (2021)

Prognostic Significance of New Immunohistochemical Markers in Refractory Classical Hodgkin Lymphoma: A Study of 59 Cases
por: Canioni, Danielle, et al.
Publicado: (2009)

Human T-lymphotropic virus type 1(HTLV-1) integration, HTLV-1-associated infective dermatitis (IDH) and the risk of Adult T cell leukaemia/lymphoma (ATLL)
por: Hlela, Carol, et al.
Publicado: (2011)

Diagnostic Approaches and Established Treatments for Adult T Cell Leukemia Lymphoma
por: Tsukasaki, Kunihiro, et al.
Publicado: (2020)

HTLV-1 proviral load in adult T-cell leukemia/lymphoma (ATLL) patients from non-endemic regions of Argentina
por: Mangano, Andrea, et al.
Publicado: (2014)

HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) versus adult T-cell leukemia/lymphoma (ATLL)
por: Zarei-Ghobadi, Mohadeseh, et al.
Publicado: (2021)

Can we cure HTLV-I associated Adult T cell Leukemia Lymphoma?
por: Bazarbachi, Ali, et al.
Publicado: (2011)

Recurrent TET2 mutations in adult T cell leukemia
por: Marçais, Ambroise, et al.
Publicado: (2014)

Recurrent TET2 mutations in adult T cell leukemia (ATL) and identification of a Single Nucleotide polymorphism in TET2 region predisposing to ATL development
por: Marçais, Ambroise, et al.
Publicado: (2015)

130 Reinhard Kurth Honorary Lecture HTLV-I and Adult T Cell Leukemia/Lymphoma (ATLL): Cellular and Molecular Basis of Transformation
por: Hall, William W, et al.
Publicado: (2014)

Potential miRNA-gene interactions determining progression of various ATLL cancer subtypes after infection by HTLV-1 oncovirus
por: Ghobadi, Mohadeseh Zarei, et al.
Publicado: (2023)

Proviral load does not discriminate patients with Human T-Cell Leukemia/Lymphoma (ATLL) from HTLV-1 carriers with a history of Strongyloidiasis
por: López, Giovanni, et al.
Publicado: (2011)

Can allo-SCT with RIC cure ATLL? Long-term survivors with excellent PS and with heterogenous HTLV-1 proviral load level
por: Uike, Naokuni, et al.
Publicado: (2011)

Decoding pathogenesis factors involved in the progression of ATLL or HAM/TSP after infection by HTLV-1 through a systems virology study
por: Zarei Ghobadi, Mohadeseh, et al.
Publicado: (2021)

Monitoring molecular response in adult T-cell leukemia by high-throughput sequencing analysis of HTLV-1 clonality
por: Artesi, M, et al.
Publicado: (2017)

Management of suspected monogenic lung fibrosis in a specialised centre
por: Borie, Raphael, et al.
Publicado: (2017)

CCR4 drives ATLL jail break
por: Shannon, Kevin M.
Publicado: (2014)

Mineral trioxyde aggregate versus calcium hydroxide in apexification of non vital immature teeth: Study protocol for a randomized controlled trial
por: Beslot-Neveu, Aurélie, et al.
Publicado: (2011)

Cis-perturbation of cancer drivers by the HTLV-1/BLV proviruses is an early determinant of leukemogenesis
por: Rosewick, Nicolas, et al.
Publicado: (2017)

Adult T-cell leukemia/lymphoma in a Caucasian patient after sexual transmission of HTLV-1
por: Sibon, David, et al.
Publicado: (2015)

Neurolymphomatosis in patient with Adult T-cell leukaemia/lymphoma (ATLL)
por: Yoshimitsu, Maki, et al.
Publicado: (2015)

Current concepts regarding the HTLV-1 receptor complex
por: Ghez, David, et al.
Publicado: (2010)

Adult T cell leukemia aggressivenness correlates with loss of both 5-hydroxymethylcytosine and TET2 expression
por: Marçais, Ambroise, et al.
Publicado: (2016)

Baseline CD8 T-cell activation is not associated with survival in ATLL
por: Taylor, Graham P, et al.
Publicado: (2015)

Clinical significance of CADM1/TSLC1/IgSF4 expression in Adult-T cell leukemia/lymphoma (ATLL): identification of various types of ATLL cells
por: Nakahata, Shingo, et al.
Publicado: (2011)

Effectiveness of lenalidomide in relapsed primary cutaneous diffuse large B‐cell lymphoma, leg type
por: Al Dhafiri, Mahdi, et al.
Publicado: (2019)

Primary cells from patients with adult T cell leukemia/lymphoma depend on HTLV-1 Tax expression for NF-κB activation and survival
por: Hleihel, Rita, et al.
Publicado: (2023)

Animal models on HTLV-1 and related viruses: what did we learn?
por: Hajj, Hiba El, et al.
Publicado: (2012)

Meta-Analysis of HTLV-1-Infected Patients Identifies CD40LG and GBP2 as Markers of ATLL and HAM/TSP Clinical Status: Two Genes Beat as One
por: Fukutani, Eduardo Rocha, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nsukl7kt61eq0rhe5j2il15n4v